about
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancerDisplayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor.Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signalsBeta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxiaNavigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.Towards the emerging crosstalk: ERBB family and steroid hormones.EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms.The EGFR R521K polymorphism influences the risk to develop colorectal cancer.SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.qCMA: a desktop application for quantitative collective cell migration analysis.An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onsetIL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes
P50
Q33261029-FDDF2D67-0D1E-4E91-A01B-9872A02FBE78Q33358967-72037BD6-6072-4FF9-AE4B-35D35990EE61Q34385041-CA6CB6DE-D436-4F5F-AD98-A27BB2E81F9AQ34504777-174CDD1E-786C-4D15-8347-CF3E06CB6F21Q35000817-94732E8A-377C-4A41-BE57-ED424A0871B1Q35049230-8A6E7F23-8B32-42AB-A34E-E00C0B806534Q35192450-9A2579C2-140C-45EA-8088-045E3ED3E19EQ35354276-6DAC1C75-59F0-4CBC-A96E-C18418C62BDFQ35545780-27263A5E-F886-43C5-93DA-2AFADCE003F7Q37124069-5132BD91-EC64-4909-9A04-49B36004B5F6Q37327479-7FF5505E-B41C-4CB3-A2AF-885B06CB1CD0Q38637973-9E115570-3A6F-4866-ACB4-B1AD7CDBCAD0Q38898387-18B9C2A8-4DEC-4C33-9788-828F68C33096Q39033394-4134BEFC-38FE-446F-BE6C-0316913ACCF3Q42727021-7F8E8A24-E45C-4CD5-8586-DF12796A6086Q48139205-CFD6BC97-7854-48EF-8E9F-C978BF78CC3AQ50992137-6E016410-2888-4080-951D-646F263C7285Q51312876-A9F619DA-DB9B-4994-A1A3-35C5A5CC654EQ53251841-D6EC76DD-A36E-4047-851A-27DD9D588DFBQ56984392-613CCE30-642F-493F-B29A-AD0DEED703A0Q56986527-B118FBA0-32F3-46B4-BDA6-C406B27E919C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mattia Lauriola
@ast
Mattia Lauriola
@en
Mattia Lauriola
@es
Mattia Lauriola
@nl
type
label
Mattia Lauriola
@ast
Mattia Lauriola
@en
Mattia Lauriola
@es
Mattia Lauriola
@nl
prefLabel
Mattia Lauriola
@ast
Mattia Lauriola
@en
Mattia Lauriola
@es
Mattia Lauriola
@nl
P106
P1153
15048255500
P21
P31
P496
0000-0002-7966-0065